Twitter Facebook Linked In Zone In Google Plus 
Research Update

Taming Two Beasts with mRNA incorporating TriLink Modified NTPs

In two impressive papers published back to back, Norbert Pardi and colleagues highlight the feasibility of using nucleoside-modified mRNA delivered via lipid nanoparticles to protect against two prominent viruses — HIV-1 and Zika virus.

While both studies used lipid nanoparticles for mRNA delivery, each study employed different immunogenic strategies. For HIV-1, Pardi et al. utilized passive immunotherapy and directly encoded an HIV-1–neutralizing antibody. For the Zika virus, the researcher team focused on active immunotherapy. In this strategy, they encoded regions of the Zika virus known to be highly immunogenic, thus provoking the body to produce its own antibodies against the virus.

"mRNA has emerged as a promising vaccine modality that can elicit potent immune responses while avoiding the safety risks and anti-vector immunity associate with some live virus vaccines,"....

Read More

Come and Meet Us
SCNAC 2017
6/4-6/9 Cesky Krumlov, CZ
Festival of Genomics
6/26-6/27 San Diego, CA
Booth 405
Featured Product
5-Methoxy-UTP Cat# N-1093.
Find what you need in our catalog of over 200 modified Nucleotides.
Magnetic Capture Beads
Accelerate your isolation process and efficiency with Nanolink™ and Magnalink™, the highest binding capacity magbeads available.

Gold Standard mRNA

TriLink's mRNA and Long RNA products set the standard for quality and performance. Our stocked mRNA portfolio includes gene editing, reporter gene, and expression factor constructs. Our custom mRNA synthesis service offers a wide array of modification options and scales ranging from micrograms to grams. All TriLink's mRNA and long RNA products offer:

  • Custom tailored support to meet specific application or program needs
  • Wide variety of modification, treatment and purification options
  • Manufactured following a 21CFR820 compliant quality system

Contact us for a quote

Animals were dosed with FLuc mRNA that was unmodified or modified. Image courtesy of Acuitas Therapeutics.
Ask An Expert

What base modifications can be incorporated into my custom mRNA or long RNA?

TriLink offers a variety of modified rNTPs suitable for in vitro transcription. We have assessed transcription efficiency based on final product formation of a 1.9 kb transcript with the following triphosphates at 100% substitution using T7 polymerase...

Read More
Zone In With Zon Blog Post

Curiously Circular RNA (circRNA) Gets Curiouser

About a year ago, my blog titled Curiously Circular RNA pointed out that circular RNA (circRNA) in animals are odd molecules in that, unlike the vast majority of other RNA in animals, circRNA have no structural beginning (5’) or end (3’). This very curious feature has, not surprisingly, stimulated....

View Blog Post


© 2017 TriLink BioTechnologies | All Rights Reserved